211 related articles for article (PubMed ID: 1607678)
21. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation.
Fiedler-Weiss VC; Buys CM
Br J Dermatol; 1987 Dec; 117(6):759-63. PubMed ID: 3501310
[TBL] [Abstract][Full Text] [Related]
22. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
23. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
[TBL] [Abstract][Full Text] [Related]
24. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin.
Fiedler VC; Wendrow A; Szpunar GJ; Metzler C; DeVillez RL
Arch Dermatol; 1990 Jun; 126(6):756-9. PubMed ID: 2140670
[TBL] [Abstract][Full Text] [Related]
25. A trial of 1% minoxidil used topically for severe alopecia areata.
Vestey JP; Savin JA
Acta Derm Venereol; 1986; 66(2):179-80. PubMed ID: 2424249
[TBL] [Abstract][Full Text] [Related]
26. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
[TBL] [Abstract][Full Text] [Related]
27. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation.
El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311
[TBL] [Abstract][Full Text] [Related]
28. Topical minoxidil for extended areate alopecia.
Frentz G
Acta Derm Venereol; 1985; 65(2):172-5. PubMed ID: 2408425
[TBL] [Abstract][Full Text] [Related]
29. Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Shapiro J; Tan J; Ho V; Tron V
J Invest Dermatol; 1995 May; 104(5 Suppl):36S. PubMed ID: 7738390
[No Abstract] [Full Text] [Related]
30. Minoxidil.
Fiedler-Weiss VC
Dermatol Clin; 1987 Jul; 5(3):627-35. PubMed ID: 3301118
[TBL] [Abstract][Full Text] [Related]
31. Action of topical minoxidil in the bald stump-tailed macaque.
Uno H; Cappas A; Brigham P
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):657-68. PubMed ID: 3558911
[TBL] [Abstract][Full Text] [Related]
32. Topical minoxidil in the treatment of androgenetic alopecia in women.
Olsen EA
Cutis; 1991 Sep; 48(3):243-8. PubMed ID: 1935254
[TBL] [Abstract][Full Text] [Related]
33. Topical minoxidil dose-response effect in alopecia areata.
Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
[TBL] [Abstract][Full Text] [Related]
34. Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial.
Ghassemi M; Yazdanian N; Behrangi E; Jafari M; Goodarzi A
Dermatol Ther; 2022 Dec; 35(12):e15943. PubMed ID: 36257912
[TBL] [Abstract][Full Text] [Related]
35. Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone.
Freyschmidt-Paul P; Hamm H; Happle R; Hoffmann R
Eur J Dermatol; 1999 Mar; 9(2):111-4. PubMed ID: 10066958
[TBL] [Abstract][Full Text] [Related]
36. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
37. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration.
Khoury EL; Price VH; Greenspan JS
J Invest Dermatol; 1988 Feb; 90(2):193-200. PubMed ID: 2448391
[TBL] [Abstract][Full Text] [Related]
39. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
[TBL] [Abstract][Full Text] [Related]
40. Australian trial of topical minoxidil and placebo in early male pattern baldness.
Connors TJ; Cooke DE; De Launey WE; Downie M; Knudsen RG; Shumack S; Eggleston AS
Australas J Dermatol; 1990; 31(1):17-25. PubMed ID: 2073205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
